Suntrust Banks’s Ionis Pharmaceuticals IONS Stock Holding History

Suntrust Banks’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$292K	Sell	4,868 -7	-0.1%	-$456	﹤0.01%	1135
2019 Q2	$313K	Buy	4,875 +219	+5%	+$15.5K	﹤0.01%	1103
2019 Q1	$378K	Buy	4,656 +99	+2%	+$6.39K	﹤0.01%	1021
2018 Q4	$246K	Buy	4,557 +114	+3%	+$5.81K	﹤0.01%	1113
2018 Q3	$229K	Buy	+4,443	New	+$209K	﹤0.01%	1170
2014 Q4	–	Sell	-6,450	Closed	-$249K	–	1240
2014 Q3	$249K	Sell	6,450 -219	-3%	-$7.76K	﹤0.01%	1246
2014 Q2	$229K	Sell	6,669 -45,688	-87%	-$1.44M	﹤0.01%	1312
2014 Q1	$2.26M	Buy	52,357 +42,658	+440%	+$2.07M	0.01%	635
2013 Q4	$385K	Buy	9,699 +75	+0.8%	+$2.67K	﹤0.01%	1389
2013 Q3	$361K	Sell	9,624 -40	-0.4%	-$1.2K	﹤0.01%	1397
2013 Q2	$259K	Buy	+9,664	New	+$206K	﹤0.01%	1478

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Suntrust Banks's IONS Position: Q3 2019 in Review

Suntrust Banks reduced its Ionis Pharmaceuticals (IONS) stake by 0.14% in Q3 2019, selling an estimated $456 and leaving 4,868 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Suntrust Banks first reported a position in IONS in Q2 2013 and has held it in 11 quarters since. The position peaked at $2.26M in Q1 2014. 370 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

Suntrust Banks held 4,868 shares of Ionis Pharmaceuticals worth $292K as of Q3 2019.
Suntrust Banks sold 7 Ionis Pharmaceuticals shares in Q3 2019, an estimated $456.
Ionis Pharmaceuticals made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1135 holding.
Suntrust Banks first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 11 quarters since.
Suntrust Banks's Ionis Pharmaceuticals position peaked at $2.26M in Q1 2014.
370 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.